Filing Overview
Registrant: Aldel Financial Inc., although the request metadata identifies Hagerty, Inc. The filing text names Aldel Financial Inc. as the registrant.
Report date: April 12, 2021; signed April 16, 2021. This Form 8-K reports the closing of Aldel’s initial public offering and related private placements.
Transaction and Financial Highlights
- Aldel sold 11,500,000 units at $10.00 per unit, including the underwriters’ full exercise of a 1,500,000-unit over-allotment option, generating $115.0 million of gross proceeds.
- Each public unit consisted of one Class A common share and one-half of one redeemable warrant. Each whole warrant is exercisable at $11.50 per share, subject to adjustment.
- The sponsor purchased 515,000 private placement units at $10.00 per unit, generating $5.15 million of gross proceeds.
- The sponsor and FG SPAC Partner LP purchased 1,300,000 out-of-the-money warrants at $0.10 per warrant, generating $130,000 of gross proceeds. These warrants are exercisable at $15.00 per share.
- Total proceeds placed in the U.S.-based trust account were $116.15 million. The filing does not provide a separate clear amount for offering expenses or net proceeds outside the trust account.
- No revenue, operating profit, net income, cash flow, margins, debt, or liquidity metrics are reported because the filing concerns the IPO and related financing transactions rather than operating results.
Material Changes and Unusual Items
- The IPO and private placements established Aldel’s post-offering capitalization and funded its trust account.
- The private placement units and out-of-the-money warrants have transfer restrictions and other rights that differ from the publicly sold securities, including cashless exercise and registration rights while held by the applicable holders.
- The out-of-the-money warrants have a $15.00 exercise price and, if held by the sponsor or permitted transferees, expire ten years after completion of the initial business combination.
- An audited balance sheet as of April 12, 2021 was filed as Exhibit 99.1.
Outlook, Risks, and Contingencies
The filing does not provide business guidance, operating outlook, management commentary, or an identified target for the initial business combination. As a SPAC, Aldel’s principal disclosed use of funds is the trust account, pending a future business combination. The filing does not state the timing, terms, or likelihood of such a transaction.
Investors should consider the potential dilution from public warrants, private placement units, and out-of-the-money warrants, as well as the transfer restrictions and special exercise, redemption, and registration provisions applicable to the privately placed securities.
Key Facts to Verify
- Confirm the correct issuer: the filing identifies Aldel Financial Inc., not Hagerty, Inc.
- Review Exhibit 99.1 for the audited April 12, 2021 balance sheet and the accounting treatment of the offering proceeds.
- Verify the $116.15 million trust account deposit and any offering expenses or amounts held outside the trust account.
- Review the warrant terms, including $11.50 public exercise pricing, $15.00 out-of-the-money warrant pricing, redemption provisions, cashless exercise rights, and expiration terms.
- Monitor future filings for the proposed initial business combination, redemption rights, dilution, and use of trust-account funds.